Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production

Scandinavian Journal of Immunology

Volumn 68, Issue 3, 2008, Pages 280-286

  Rokka, S ^a,b   Myllykangas, S ^c   Joutsjoki, V ^a  

^a FINNISH FOREST RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; INTERLEUKIN 8;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; COLONY FORMING UNIT; COLOSTRUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ANIMALS; ANTIBODIES; BACTERIAL ADHESION; BIOLOGICAL PRODUCTS; CATTLE; CELL LINE, TUMOR; COLOSTRUM; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERLEUKIN-8; LACTOBACILLUS; PREGNANCY; PROBIOTICS;

EID: 48749087110     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02138.x     Document Type: Article

References (45)

1. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut 2007 56: 772 81.
2. Cavallaro LG, Egan B, O'Morain C, Di Mario F. Treatment of Helicobacter pylori infection. Helicobacter 2006 11 (Suppl 1 36 9.
3. Cremonini F, Canducci F, Di Caro S et al. Helicobacter pylori treatment: a role for probiotics? Dig Dis 2001 19: 144 7.
4. Felley C, Michetti P. Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol 2003 17: 785 91.
5. Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003 22: 360 6.
6. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998 93: 2097 101.
7. Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998 64: 4573 80.
8. Michetti P, Dorta G, Wiesel PH et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999 60: 203 9.
9. Oh Y, Osato MS, Han X, Bennett G, Hong WK. Folk yoghurt kills Helicobacter pylori. J Appl Microbiol 2002 93: 1083 8.
10. Kim TS, Hur JW, Yu MA et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 2003 66: 3 12.
11. Lorca GL, Wadstrom T, Valdez GF, Ljungh A. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 2001 42: 39 44.
12. Cats A, Kuipers EJ, Bosschaert MA, Pot RG, Vandenbroucke-Grauls CM, Kusters JG. Effect of frequent consumption of a Lactobacillus casei containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 2003 17: 429 35.
13. Sgouras D, Maragkoudakis P, Petraki K et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004 70: 518 26.
14. Ryan KA, Daly P, Li Y, Hooton C, O'Toole PW. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother 2008 61: 831 4.
15. Rokka S, Pihlanto A, Korhonen H, Joutsjoki V. In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett Appl Microbiol 2006 43: 508 13.
16. Marnila P, Rokka S, Rehnberg-Laiho L et al. Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 2003 8: 192 201.
17. Shin JH, Yang M, Nam SW et al. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin Diagn Lab Immunol 2002 9: 1061 6.
18. Casswall TH, Nilsson HO, Bjorck L et al. Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J Gastroenterol 2002 37: 1380 5.
19. Crabtree JE, Farmery SM, Lindley IJ, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994 47: 945 50.
20. Rieder G, Hatz RA, Moran AP, Walz A, Stolte M, Enders G. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun 1997 65: 3622 30.
21. Beswick EJ, Bland DA, Suarez G, Barrera CA, Fan X, Reyes VE. Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect Immun 2005 73: 2736 43.
22. Beswick EJ, Das S, Pinchuk IV et al. Helicobacter pylori-induced IL-8 production by gastric epithelial cells up-regulates CD74 expression. J Immunol 2005 175: 171 6.
23. Fan X, Crowe SE, Behar S et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med 1998 187: 1659 69.
24. Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol, 2007 21: 237 59.
25. Tamminen M, Joutsjoki T, Sjoblom M et al. Screening of lactic acid bacteria from fermented vegetables by carbohydrate profiling and PCR-ELISA. Lett Appl Microbiol 2004 39: 439 44.
26. Tamminen M, Mäki M, Joutsjoki T, Ryhänen EL, Joutsjoki V. Differentation of lactobacilli related to Lactobacillus plantarum from naturally fermented cucumbers and white cabbage. Appl Biotech Food Sci Policy 2003 1: 125 8.
27. Shmuely H, Burger O, Neeman I et al. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular weight constituent of cranberry. Diagn Microbiol Infect Dis 2004 50: 231 5.
28. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O. SAS for Mixed Models. Cary, NC: SAS Institute Inc., 2006.
29. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997 53: 983 97.
30. Tamura A, Kumai H, Nakamichi N et al. Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain. J Gastroenterol Hepatol 2006 21: 1399 406.
31. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997 41: 49 55.
32. Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A. Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin Diagn Lab Immunol 2005 12: 1378 86.
33. Ko JS, Yang HR, Chang JY, Seo JK. Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha. World J Gastroenterol 2007 13: 1962 5.
34. Zhang L, Li N, Caicedo R, Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 2005 135: 1752 6.
35. McCracken VJ, Chun T, Baldeon ME et al. TNF-alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp Biol Med (Maywood) 2002 227: 665 70.
36. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 2004 72: 5308 14.
37. Ma FZ, Ma HS, Yu Q, Han SX. Effects of Lactobacilli on regulating NF-kappaB activation and IL-8 secretion in SGC7901 cell impacted by Helicobacter pylori. Sichuan Da Xue Xue Bao Yi Xue Ban 2007 38: 795 8.
38. Tuomola EM, Salminen SJ. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998 41: 45 51.
39. Myllyluoma E. The Role of Probiotics in Helicobacter pylori Infection. Helsinki: Helsinki University Printing House, 2007.
40. Loimaranta V, Carlen A, Olsson J, Tenovuo J, Syvaoja EL, Korhonen H. Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. J Dairy Res 1998 65: 599 607.
41. Korhonen H, Syvaoja EL, Ahola-Luttila H et al. Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol 1995 78: 655 62.
42. Early EM, Hardy H, Forde T, Kane M. Bactericidal effect of a whey protein concentrate with anti-Helicobacter pylori activity. J Appl Microbiol 2001 90: 741 8.
43. Dial EJ, Hall LR, Serna H, Romero JJ, Fox JG, Lichtenberger LM. Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig Dis Sci 1998 43: 2750 6.
44. Wei H, Loimaranta V, Tenovuo J et al. Stability and activity of specific antibodies against Streptococcus mutans and Streptococcus sobrinus in bovine milk fermented with Lactobacillus rhamnosus strain GG or treated at ultra-high temperature. Oral Microbiol Immunol 2002 17: 9 15.
45. Wei H, Xu Y, Xiong Y, Xu F, Liu G. Synergistic antidigestion effect of Lactobacillus rhamnosus and bovine colostrums in simulated gastrointestinal tract (in vitro). Appl Microbiol Biotechnol 2007 75: 619 26.